Introduction
An earlier investigation 1 studied mortality and cancer incidence in 1,807 workers employed at a factory manufacturing semiconductors in the West Midlands, UK. Mortality was investigated for the period 1970-82, and cancer incidence for the period 1971-81. The mortality findings were unexceptional, although an excess of borderline statistical significance was reported for the incidence of malignant melanoma (Obs 3, Exp 0.68, SRR 441, p=0.06). This excess was not associated with duration of employment, either in the plant as a whole or in the photomasking process, a procedure known to involve ultraviolet light exposure. A more recent update of this study, with a further seven years of follow-up, found no additional cases of malignant melanoma. 2 In 2003, the Health and Safety Executive (HSE) reported cancer incidence and mortality in a cohort of 4,388 semiconductor manufacturing workers based at a factory in Scotland, following concern that there might be a cluster of cancers at the facility. 3 Overall mortality and cancer incidence was below or close to expectation. Based on rates for the general population of Scotland, a statistically significant excess (incidence and mortality) of lung cancer was found in female workers, along with a significant excess of stomach cancer (based on three cases) and a non-significant excess of breast cancer (based on 20 cases). In male workers there was a nonsignificant excess of deaths from cancer of the brain, based on three deaths.
In the light of the findings of the HSE report, and editorials expressing concern about cancer risks in the semiconductor manufacturing industry, 4, 5 it was clear that further information was required on this topic. It was decided, therefore, to incorporate a further 13 years of mortality and cancer incidence data into the West Midlands study 2 , with the aim of identifying causes of death or sites of cancer that merited further investigation.
Materials and Methods
Identification particulars were available for 1,807 (281 males and 1,526 females) workers employed at a semiconductor manufacturing facility. The cohort comprised a "census" cohort in employment on 1 st January 1970 (758 employees) together with an "entry" cohort that commenced employment between 1 st January 1970 and 31 st December 1979 (1,049 employees). [A previous report noted 759 employees in the survivor population and 1,048 in the entry cohort. 1 These figures have been revised after checking the employment dates.] All workers had a minimum period of employment of one month. Some 88% of the cohort was employed for twelve months or more.
Semiconductor production started on the site in 1966. In the 1980s, departments included the plating shop, assembly, wafer plating, diffusion (incorporating photomasking), chemical processing and the test area. A wide variety of chemicals was in use at the plant including hydrochloric acid, sulphuric acid, nitric acid, phosphoric acid, boric acid, acetic acid, chloroauric acid, hydrofluoric acid, nickel sulphate, nickel chloride, sodium hydroxide, potassium hydroxide, gold potassium cyanide, copper cyanide, potassium cyanide, silver cyanide, tin sulphate, chromium trioxide, methylene chloride, trichloroethylene, tricholoroethane, cyclohexane, methylated spirits, ethylmethylketone, acetone, ethoxyethanol, lead solder, and epoxy resin. Work history data currently available to the study team is limited to dates of hire and leaving employment; full work histories (dates of working in different departments) were not abstracted at the time of the study inception. In addition, duration of employment at the plant was based solely on periods of employment before 31 st March 1983.
The National Health Service Central Register (NHSCR) of the Office for National Statistics (ONS) provided information on the vital status of each study subject on the closing date of the survey, 31 st December 2002. Vital status information is summarised in Table 1 2 subjects who could not be traced by ONS were traced either by the Department of Social Security (DSS), by searching the electoral register or because they were still employed at the company. Further use has not been made of these latter tracing procedures.
1
The mortality experience of the cohort was compared with that which might have been expected to occur if mortality rates for the general population of England and Wales for the period 1966-2000 had been operating on the study cohort, having due regard to the composition of the study cohort by sex, age (five year age groups) and calendar period (five year calendar periods). Expectations based on person-years at risk (pyr) were calculated using the PersonYears computer program. 6 Study subjects entered the pyr on completion of one month employment or st January 1970, whichever was later. Individuals ceased to contribute to the pyr on the date of death, date of embarkation, the date they were last confirmed to be alive or the closing date of the study, whichever was the earlier. Study subjects made no contribution to observed or expected numbers after their 85 th birthday. There are three reasons for this censoring. Firstly, published mortality rates are only available for the "open ended" age group ≥85 years and the distribution of the cohort pyr by single years of age may be very different to that of the general population; secondly, the reliability of cause of death particulars is probably poorer at later ages; and thirdly, any study subjects incorrectly coded as traced alive at the end of the study would have a disproportionate effect on the expected numbers for the open ended age group.
In a similar manner, the cancer morbidity experience of the cohort was compared with expectations based on cancer incidence rates for England and Wales for the period 1971-2000. For these analyses subjects could not enter the pyr before 1 st January 1971. Employees traced by sources other than the NHSCR are not included in analyses of cancer incidence.
Standardised mortality ratios (SMRs) and standardised registration ratios (SRRs) were calculated as the ratio of observed to expected numbers of deaths expressed as a percentage. In calculating p-values and 95% confidence intervals (95% CIs), deaths and cancer registrations were assumed to occur as a Poisson process. In addition, evidence was sought for any trend (linear component) in the pattern of SMRs or SRRs (e.g. any tendency for SMRs to increase or decrease with time since first employment). 7 Tests of heterogeneity were also carried out (e.g. could the differences in SMRs by duration of employment represent no more than random variation in sub-groups). 7 Both tests assume a similar null hypothesis; no trend and homogeneous SMRs or SRRs. Small P-values indicate statistical significance, either that the trend or the amount of heterogeneity is unlikely to have occurred by chance alone. All significance tests were two-tailed. Table 3 shows observed and expected numbers of deaths for individual sites of cancer for male and female employees. The only findings for which there were significant differences between observed and expected numbers were deficits for cancer of the breast in females (Obs 13, Exp 27.38, SMR 47) and cancer of the oesophagus in males and females combined (Obs 0, Exp 4.03). Sites of cancer that warranted further investigation were then selected. Cancers of the stomach, lung, brain and breast (female) were selected on the basis of findings from the HSE study of semiconductor workers. 3 In addition, cancer of the rectum, cancer of the pancreas and malignant melanoma were selected because of the excess incidence of these cancers in the current study.
Results
Observed and expected numbers of deaths by year of hire, time since first employment and duration of employment are shown for stomach cancer, rectal cancer, pancreatic cancer, lung cancer, malignant melanoma, breast cancer and cancer of the brain in Tables 5-11 , respectively. Confidence intervals (95%) are only shown for those SMRs based on two or more observed deaths. In these analyses the numbers of deaths available were small and no significant trends or significant heterogeneity were found in any set of SMRs. Table 12 shows observed and expected numbers of registrations for cancer of the stomach by year of hire, time since first employment and duration of employment. Numbers of cases were small and no significant trends or significant heterogeneity were found in any set of SRRs. Table 13 shows observed and expected numbers of registrations for cancer of the rectum by year of hire, time since first employment and duration of employment. There was no significant trend or significant heterogeneity in any set of SRRs. There was a significantly elevated SRR for workers (males and females) first employed in the 1970s (Obs 11, Exp 4.45, SRR 247). Table 14 shows observed and expected numbers of registrations for cancer of the pancreas by year of hire, time since first employment and duration of employment. There was no significant trend or significant heterogeneity in any set of SRRs. All cases occurred in workers first employed in the period 1960-79. Table 15 shows observed and expected numbers of registrations for cancer of the lung and bronchus by year of hire, time since first employment and duration of employment. There was no significant trend or significant heterogeneity in any set of SRRs, and all category-specific SRRs were unexceptional. Table 16 shows observed and expected numbers of registrations for malignant melanoma by year of hire, time since first employment and duration of employment. There was no significant trend or significant heterogeneity in any set of SRRs. All cases occurred in workers first employed in the period 1960-79. Table 17 shows observed and expected numbers of registrations for cancer of the breast by year of hire, time since first employment and duration of employment among female employees. SRRs by year of hire showed significant heterogeneity (p=0.02) and a significant negative trend with year of hire (p=0.01), i.e. there were lower SRRs with recent decades of hire. In addition, the positive trend with duration of employment approached statistical significance (p=0.06). This trend was based on unusually low incidence in the short duration of employment category (<5y) rather than unusually high incidence in the longest category of duration (≥10y). Table 18 shows observed and expected numbers of registrations for cancer of the brain by year of hire, time since first employment and duration of employment. There were only two cases available for analysis. 
Discussion
This study has found significantly elevated morbidity for cancer of the rectum and malignant melanoma in the total study cohort (males and females combined). In addition, there was significantly elevated morbidity for cancer of the pancreas, but in female employees only. For cancer of the rectum and malignant melanoma the excess cancer morbidity risks were not mirrored in the corresponding mortality findings. Confident explanations for such disparities are not available. The overall excess of melanoma incidence incorporates the original reported excess 1 , and this cohort study should be viewed as providing a single report of melanoma excess and not two such reports. There was no suggestion of excess risks in this cohort of semiconductor workers for stomach cancer, lung cancer, breast cancer or cancer of the brain. More specifically, there was a significant deficit of deaths for female breast cancer and the corresponding deficit for cancer incidence approached formal levels of statistical significance.
The most important limitation to be attached to this study is the absence of job history information and the consequent absence of exposure histories. [At the time of the original data abstraction in the 1980s, the intention was that work history data, if required, would be considered in nested case-control studies.] It was not possible therefore to make any comparisons between workers employed in different departments. Attempts to identify whether any of the excess risks might be occupationally related were limited to analyses of risks by year of hire, period from first employment and duration of employment. These analyses did not suggest that any of the three cancers in excess (cancer of the rectum, cancer of the pancreas, malignant melanoma) were occupationally related. The absence of work history data means, however, that these latter analyses are of limited value and, if work history records are still available, more informative analyses of occupational exposures need now to be carried out. A minor limitation of the study is that workers who ceased employment before 1970 could not be included in the cohort because factory records for these employees had been destroyed.
There is only one other cohort study (with published findings) of workers engaged in semiconductor manufacture. 3 Excess risks reported by one study are not replicated in the other, and vice versa. This may indicate that occupational exposures in the two facilities are very different and that different sets of occupational cancer risks are present. Alternatively, it is possible that occupational factors are not involved in the cancer excesses at either facility. Various intermediate scenarios can also be envisaged. Elucidation of possible cancer risks in the semiconductor manufacturing industry will require more detailed epidemiological analyses and the initiation of further cohort studies. It will be important that such studies are carried out on complete cohorts of workers and not on volunteers.
